PCI Biotech Holding ASA
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$20,315,000 and profit margin reached -679%. Total operating expenses were $25,231,000.

Profit Margin

PCI Biotech Holding ASA (OSE:PCIB.OL): Profit margin
2014 0 -35.84M
2015 0 -31.92M
2016 0 -32.18M
2017 0 -42.84M
2018 0 -34.78M
2019 0 -89.25M
2020 0 -72.63M
2021 0 -88.48M
2022 0 -53.74M
2023 2.99M -20.31M -679.43%

PCIB.OL Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
2.99M000000000
Cost of revenue
0633K2.54M2.20M955K5K6K15.89M15.31M0
Gross profit
2.99M-633K-2.54M-2.20M-955K-5K-6K-15.89M-15.31M0
Operating exp.
Research and development
15.62M44.75M71.70M75.57M83.31M40.33M40.98M39.21M38.84M39.34M
Selling and marketing
0000000000
Total operating expenses
25.23M56.44M86.02M82.12M88.80M44.51M43.43M33.02M32.62M36.49M
Operating income
-22.24M-56.44M-86.02M-82.12M-88.80M-44.51M-43.43M-33.02M-32.62M-36.47M
Other income (expenses), net
1.92M1.35M-2.36M9.88M58K9.73M590K843K706.99K632K
Income before tax
-20.31M-55.09M-88.39M-72.23M-88.74M-34.78M-42.84M-32.18M-31.92M-35.84M
Income tax expense
0-1.35M89K397K506K9.85M590K847K707K650K
Net income
-20.31M-53.74M-88.48M-72.63M-89.25M-34.78M-42.84M-32.18M-31.92M-35.84M
Earnings per share
Basic EPS
-0.54-1.44-2.37-1.95-2.4-1.25-1.76-2.01-2.12-3.22
Diluted EPS
-0.54-1.44-2.37-1.95-2.4-1.23-1.73-1.99-2.11-3.04
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source